LRK-4189, which targets PIP4K2C, a key cancer cell fitness target, is being developed for microsatellite stable (MSS) colorectal cancer (CRC) and other solid tumors Clinical study begins with healthy participants to establish early tolerability, pharmacokinetics, and pharmacodynamics CAMBRIDGE, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) — Larkspur Biosciences, a company pioneering a new wave in cancer […]

Presentation highlights novel methodologies for measuring clinical outcomes, including seizure frequency and behavioral changes, in currently recruiting Phase 3 study in GRIN-relatedneurodevelopmental disorder (GRIN-NDD) GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies to treat serious neurodevelopmental disorders, today announced that it will presentinsights on the development of novel rating scales for

Axon Vision (TASE: AXN) announced today a strategic cooperation agreement with Leonardo DRS to pursue opportunities in advanced situational awareness, lethality, and survivability, with special emphasis on Counter-UAS (C-UAS) solutions in the U.S. defense market. The partnership is expected to address a critical demand for on-platform AI-driven capabilities that support force protection and platform modernization.

Woodford to offer affordable new homes in Thomasville, NC from the high $200s Century Communities, Inc. (NYSE: CCS)-a top national homebuilder, industry leader in online home sales, and featured on America's Most Trustworthy Companies and World's Most Trustworthy Companies by Newsweek-announced that the Company's Century Complete brand will soon offer new homes from the high

MyOme, a leading clinical whole-genome testing and polygenic risk modelling (PRS) company, today announced a strategic partnership with Ms.Medicine, a national network of women's health and concierge primary care practices. Together, the organizations are pioneering a new model for primary care -one where comprehensive, proactive genomic insights are seamlessly integrated into everyday patient care. https://mma.prnewswire.com/media/1829079/MyOme_Logo.jpg

Concorde announced today that Chief Due Diligence Officer Amy Arnold has been elected to serve on theADISA board of directors for the 2026 – 2027 term. https://mma.prnewswire.com/media/2771548/Concorde_Logo.jpg “Amy's dedication to serving financial professionals, sponsors and the alternative investments industry perfectly aligns with ADISA's mission,” said Danielle Delongchamp, president and chief executive officer of Concorde. “For

Partnership will Expand Shoulder Innovations' Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Management to Participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference Today at 8:30 a.m. ET Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively

Mayhugh Commercial Advisors is pleased to announce that Pape Dawson, a nationally recognized engineering and consulting firm with more than 40 offices across the United States, has signed a 14,000-square-foot lease at the prestigious Renaissance Office Building, located at 9530 Market Place Road in Fort Myers.The Class A building, owned byCM-CRE Office I, LLLP, is

Reseda Group, a wholly owned credit union service organization of MSU Federal Credit Union (MSUFCU), today announced it is partnering with LetMeDoIt, a groundbreaking decision-making app designed to empower people with disabilities to take ownership of their choices and strengthen their independence. https://mma.prnewswire.com/media/2836999/Reseda_Group_Partners_with_LetMeDoIt.jpg “Reseda Group is proud to invest in LetMeDoIt and support a technology

CIMG Inc. (“CIMG” or the “Company”) (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing to enhance its business partners' sales growth and commercial value, today announced that its Board of Directors and majority Shareholders have approved a 20-for-1 reverse stock split of its common stock. On